The docking of synaptic vesicles on the presynaptic membrane induced by α-synuclein is modulated by lipid composition
File(s)s41467-021-21027-4.pdf (1.38 MB)
Published version
Author(s)
Type
Journal Article
Abstract
α-Synuclein (αS) is a presynaptic disordered protein whose aberrant aggregation is associated with Parkinson’s disease. The functional role of αS is still debated, although it has been involved in the regulation of neurotransmitter release via the interaction with synaptic vesicles (SVs). We report here a detailed characterisation of the conformational properties of αS bound to the inner and outer leaflets of the presynaptic plasma membrane (PM), using small unilamellar vesicles. Our results suggest that αS preferentially binds the inner PM leaflet. On the basis of these studies we characterise in vitro a mechanism by which αS stabilises, in a concentration-dependent manner, the docking of SVs on the PM by establishing a dynamic link between the two membranes. The study then provides evidence that changes in the lipid composition of the PM, typically associated with neurodegenerative diseases, alter the modes of binding of αS, specifically in a segment of the sequence overlapping with the non-amyloid component region. Taken together, these results reveal how lipid composition modulates the interaction of αS with the PM and underlie its functional and pathological behaviours in vitro.
Date Issued
2021-02-10
Date Acceptance
2021-01-07
Citation
Nature Communications, 2021, 12
ISSN
2041-1723
Publisher
Nature Research
Journal / Book Title
Nature Communications
Volume
12
Copyright Statement
© The Author(s) 2021. This article is licensed under a Creative CommonsAttribution 4.0 International License, which permits use, sharing,adaptation, distribution and reproduction in any medium or format, as long as you giveappropriate credit to the original author(s) and the source, provide a link to the CreativeCommons license, and indicate if changes were made. The images or other third partymaterial in this article are included in the article’s Creative Commons license, unlessindicated otherwise in a credit line to the material. If material is not included in thearticle’s Creative Commons license and your intended use is not permitted by statutoryregulation or exceeds the permitted use, you will need to obtain permission directly fromthe copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
License URL
Sponsor
Medical Research Council (MRC)
Medical Research Council (MRC)
Commission of the European Communities
The Leverhulme Trust
Grant Number
MR/N000676/1
MR/R000255/1
819644
RPG-2015-345
Publication Status
Published
Article Number
ARTN 927